Genetic and non-genetic factors affecting the response to clopidogrel therapy. - Wikidata - awgldk - TriplyDB

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

http://www.wikidata.org/entity/Q37991382

about

Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel Association of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients.Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients.P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy.Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.The discovery and development of prasugrel.Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.

P2860

Q34805121-419D042D-974C-49A3-96C7-19432FDE2E16 Q37506535-9C6ECE01-41EB-4E83-A475-2258D7CC473B Q37639546-4788217B-5D6B-4610-811F-19F5D290C48F Q37686892-8A5AD88D-CE3B-4485-9709-7E832576B44B Q38817051-050744E5-FA4A-451A-912A-1F4F49C66EF0 Q38974884-FFE6FD10-FE9F-4DB2-852A-3EB7BE4A9874 Q41242987-87CD1C15-B363-47E1-BA87-1B68AD1B7A6D Q41511099-37C1CBA2-FC98-4E96-B065-96198A31043C Q47094164-B590DDEC-8005-4BEA-8772-B6CA2AAF22EF Q51059883-9ECA52B4-CFCF-41FC-AD9D-6C076FEFC09E Q51342808-03FF1BDD-7660-47A0-B48B-30844D263EB1 Q51816112-28E131A7-B7C0-4BBF-A0E8-F6158E31A073 Q53584028-C5266B21-343E-4D6B-AF1A-2AE68E8D9CEC

P2860

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

http://www.wikidata.org/entity/Q37991382

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@en

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@nl

type

label

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@en

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@nl

prefLabel

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@en

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

@nl

P1433

Q37991382-AC8390C4-BA11-46C9-9F55-80B65FCDBAA4

P1476

Q37991382-0686E422-0361-4EA1-B585-C609BF44D36E

P2093

Q37991382-7C47CAF6-4F4E-439D-944F-51AB1BAFED9D

P2860

Q37991382-0051E0D1-B7B1-4820-8BE4-E72CD3DAAB85

Q37991382-046F17BC-6052-44A6-BDAA-06AB2ECBFAED

Q37991382-0907BCEA-B272-477A-BF72-D39CB20084F3

Q37991382-09A0B559-A3B1-4112-86B5-33E6DD4BB0F7

Q37991382-09F715D1-FB2A-4E46-894C-6B4BA135B181

Q37991382-0A0DDEDB-18AA-4312-89EF-3E066CC501B6

Q37991382-0D617EF3-ACF2-48BD-8F2D-03630D96AF85

Q37991382-11528FAE-538B-48B4-9CF9-2D1242477713

Q37991382-12F0863D-CCAC-4C3F-B0BC-E80A20B1DFF1

Q37991382-138FBD8A-2C5F-442F-B560-A4073C2DF21E

P304

Q37991382-A0B20B32-C0F2-44AA-8C28-58FDF0F320CF

P31

Q37991382-A285C6BB-5C3A-4737-B83D-35AC2BCB0A05

P356

Q37991382-1E5D3C17-0EC2-4DCB-BE5F-11B44E1708BB

P407

Q37991382-1D55FC4F-3219-439C-ADFD-3DCEFD598001

P433

Q37991382-F1EF69A0-AE2E-4AB8-9613-C43A394C1EA9

P478

Q37991382-68687D2A-2840-4517-B6D5-1B4125C93522

P50

Q37991382-4188FC81-9603-4DE4-8C9F-BC13C3AF298D

Q37991382-7723CB17-E2DA-4C8C-BDBE-9F9524DB1155

P577

Q37991382-58BEC499-7B67-4AE8-AD77-4337422CDA50

P5875

Q37991382-D41EF580-5AFE-44E3-A454-B874A4776ACC

P698

Q37991382-F51B045B-4974-4462-9A5A-BF5A18B89122

P921

Q37991382-5552FD21-11D3-40B5-84DF-81DC80A06252

P356

14656566.2012.666524

P1433

Expert Opinion on Pharmacotherapy

P1476

Genetic and non-genetic factors affecting the response to clopidogrel therapy

@en

P2093

Franciszek Główka

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

P2Y12, a new platelet ADP receptor, target of clopidogrel

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?

P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose

Clopidogrel resistance: role of body mass and concomitant medications

P304

663-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.666524

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Dorota Danielak

Marta Karaźniewicz-Łada

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221684135

http://www.w3.org/2001/XMLSchema#string

P698

22397459

http://www.w3.org/2001/XMLSchema#string

P921